San Francisco – March 4, 2021 – Diabetes is one of the most prevalent chronic diseases in...

SAN FRANCISCO, July 20, 2020 /PRNewswire/ -- Pendulum Therapeutics, an evidence-based microbiome company, announced today the publication of their clinical...

SAN FRANCISCO, June 4, 2020 /PRNewswire/ -- Pendulum Therapeutics, a cutting-edge microbiome company dedicated to making people healthier through microbiome-targeted solutions, announced...

SAN FRANCISCO, May 26, 2020 /PRNewswire/ -- Pendulum Therapeutics, an evidence-based microbiome company, is proud to announce that CEO and Co-Founder Colleen...

SAN FRANCISCO, March 30, 2020 (GLOBE NEWSWIRE) -- Pendulum Therapeutics, an evidence-based microbiome company, announced today that veteran health...

SAN FRANCISCO, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Pendulum Therapeutics, an evidence-based microbiome company, announced today the formation of...

SAN FRANCISCO, November 4, 2019 – California Life Sciences Institute (CLSI), the non-profit affiliate of California Life Sciences Association (CLSA), has appointed Colleen...

SAN FRANCISCO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Pendulum Therapeutics today announced that the California Life Sciences Association (CLSA) has...

SAN FRANCISCO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Whole Biome, an evidence-based microbiome company, announced today that it...